跳至主要内容
临床试验/NCT05528068
NCT05528068招募中不适用

Effect of Lifestyle Intervention Based on Continuous Physiological Monitoring Among Patients With Hypertension or High-normal Blood Pressure

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2022年7月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
424
试验地点
1
主要终点
Change in peak oxygen uptake (VO2peak) from baseline to 3 months

研究概览

简要总结

Hypertension is a major risk factor for cardiovascular disease and cardiovascular events. Healthy lifestyle factors are widely recommended for hypertension prevention and control, and cardiorespiratory fitness is a strong and independent predictor of the progression of hypertension. Increased cardiorespiratory fitness through lifestyle modifications is associated with lower mortality in hypertensive or high-normal blood pressure individuals. The aim of the study is to evaluate the effects of supervised lifestyle intervention that include diet and exercise and base on intelligent application and continuous physiological monitoring on improvement of cardiopulmonary fitness, blood pressure and other health outcomes among participants with hypertension or high-normal blood pressure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • who is ≥18 years old and < 70 years old;
  • hypertension or high-normal blood pressure;
  • who has a smart phone and can use it (android phones are preferred).

排除标准

  • with acute myocardial infarction, acute tachyarrhythmia, pulmonary edema, severe aortic stenosis and other serious circulatory diseases or respiratory diseases;
  • with acute cardiovascular and cerebrovascular diseases;
  • poor blood pressure control;
  • with physical limitations(e.g., restricting injuries of the musculoskeletal system, such as fractures, unstable joints and other physical diseases);
  • with skin disease or skin damage at the site of wearable device;
  • with mental disorder, epilepsy or other diseases resulting in inability to control the body;
  • pacemaker installation;
  • woman who is during pregnancy or prepare for pregnancy;
  • sensitive skin for wearable devices; 10)refuse to provide written informed consent.

结局指标

主要结局

Change in peak oxygen uptake (VO2peak) from baseline to 3 months

时间窗: baseline, 3 months

VO2peak is obtained by a graded cardiopulmonary exercise test to assess cardiorespiratory fitness, which is measured at baseline, 3 months.

次要结局

  • Change in upper limb muscle endurance(baseline, 3 months, 6 months and 9 months)
  • Change in cardiopulmonary exercise test-derived total time of exercise(baseline, 3 months and 9 months)
  • Change in cardiopulmonary exercise test-derived peak metabolic equivalents (METs)(baseline, 3 months and 9 months)
  • Change in concentrations of serum lipids and lipoproteins(baseline, 3 months and 9 months)
  • Change in cardiopulmonary exercise test-derived anaerobic threshold (AT)(baseline, 3 months and 9 months)
  • Change in cardiopulmonary exercise test-derived VE/VCO2-slope(baseline, 3 months and 9 months)
  • Change in cardiopulmonary exercise test-derived maximal heart rate(baseline, 3 months and 9 months)
  • Change in lower limb muscle endurance(baseline, 3 months, 6 months and 9 months)
  • Change in systolic blood pressure(baseline, 3 months, 6 months and 9 months)
  • Change in cardiopulmonary exercise test-derived peak respiratory exchange ratio (RERpeak)(baseline, 3 months and 9 months)
  • Change in cardiopulmonary exercise test-derived VO2/HR(baseline, 3 months and 9 months)
  • Change in concentration of fasting serum glucose(baseline, 3 months and 9 months)
  • Change in peak oxygen uptake (VO2peak) from baseline to 9 months(baseline, 9 months)
  • Change in diastolic blood pressure(baseline, 3 months, 6 months and 9 months)
  • Change in cardiopulmonary exercise test-derived oxygen uptake efficiency slope (OUES)(baseline, 3 months and 9 months)
  • Change in physical activity level(baseline, 3 months, 6 months and 9 months)
  • Change in handgrip strength(baseline, 3 months, 6 months and 9 months)
  • Change in upper and lower limbs and body flexibility(baseline, 3 months, 6 months and 9 months)
  • Change in balance ability(baseline, 3 months, 6 months and 9 months)
  • Change in dietary intake(baseline, 3 months, 6 months and 9 months)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Xue Feng

Executive Deputy Director

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验

Effect of Lifestyle Intervention Among Patients With... | 临床试验